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Introduction 
In patients with chronic kidney disease (CKD), 
especially those on hemodialysis (HD), nutritional status 
plays an important role. It is directly connected with longevity, 
life quality, rate of hospitalization and mortality 1–5. Despite 
the fact that dialysis procedure is constantly improving, 
common complication in HD patients is still protein-energy 
wasting (PEW). Although PEW is a very common problem, 
it often remains undiagnosed and untreated. Also, PEW is 
the strongest risk factor for poor clinical outcomes, including 
death, especially in the elderly patients 4, 6. 
Considering that CKD has a high prevalence of 13.4%, 
and the number of patients with diagnosed CKD is growing 
worldwide, including the fact that annual mortality of 
dialysis patients was 20% higher compared to the mortality 
from cancer disease, the seriousness and the magnitude of 
the problem in patients with PEW seems to be much higher 2,
7. Several studies related to the nutritional status in the HD
patients have shown that the prevalence of PEW varies from 
less than 20% to almost 80% depending on markers used for 
assessment of the nutrition status 4, 8, 9. Many different terms, 
such as protein-energy malnutrition, uremic malnutrition, 
uremic cachexia, malnutrition-inflammation syndrome, are 
used for a condition associated with loss of muscle and fat, 
malnutrition, and inflammation in patients with CKD, and 
may lead to confusion and misinterpretation of clinical data. 
The existence of different criteria can produce the 
problems in diagnostic procedures, comparison of results and 
establishing recommendations for the prevention and 
therapy. Therefore, in order to avoid confusion in the 
nomenclature, the International Society of Renal Nutrition 
and Metabolism (ISRNM) expert panel has recommended 
the term “protein-energy wasting” to describe a “state of 
decreased body stores of protein and energy fuels” that 
usually results from a complex interplay of reduced nutrient 
intake and/or increasing catabolism 10. Since protein and 
energy wasting sometimes occur as separate entities, terms 
“protein wasting” or “energy wasting” can be used to refer to 
the occurrence of only one of the mentioned 10. 
Etiology of PEW 
Dialysis patients often develop malnutrition at a very 
early stage of dialysis 9, 11, 12. PEW in patients with CKD, 
particularly those who are on HD, has its own specificity as 
compared to patients who suffer from other chronic diseases 
or those in which it is only the result of insufficient food 
intake or restrictive diets. Many factors that contribute to 
PEW are directly associated with chronic renal failure 2, 13, 14. 
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The possible causes of PEW in CKD patients are listed in 
Table 1, created and presented from the ISRNM as a 
consensus review of current knowledge 13. 
A long list of causes and variety of their combination 
can lead to PEW in different ways in each HD patient. 
Although the etiology of PEW is undoubtedly multifactorial, 
inadequate dietary nutritional intake is likely to play an 
important role. Predialysis patients are mostly on low-protein 
diets. Sometimes these types of diets are hypocaloric and as 
a consequence of predialysis restrictive diets, patients start 
HD in poor nutritional conditions 9, 11, 12, 15. Hemodialysis 
procedure itself can directly affect energy balance, i.e. 
energy intake and energy expenditure. Several studies 
indicated that dietary energy and protein intakes were below 
recommended levels or the actual needs in the HD patients 9, 16–18. 
In addition, the progressive reduction in spontaneous food 
intake occurs with a decrease in kidney function 18. Factors 
that affect food intake including not only dietary restrictions, 
but also anorexia, taste changes, depression, social behavior, 
customs, low social status, solitude, and inability to obtain or 
prepare food 2, 16, 19. 
Anorexia in the HD patients may develop as a result of 
nitrogen-based uremic toxin retention as well as 
dysregulation in some of appetite mediators – from gastric, 
cytokines and adipokines to hypothalamic amino acid 
sensing 2, 13, 15, 20, 21. Malnutrition in the HD patients is also 
often caused by too many restrictive or monotony diets, 
sometimes due to unnecessary prohibition of various foods 
without considering the preferences, needs and possibilities 
of patients 15. Furthermore, the imbalance between dietary 
intake and actual needs can be increased by additional loss of 
nutrients during dialysis, such as amino acids, certain 
peptides, glucose, vitamins, trace elements, leading to further 
increased risk of PEW 13, 15. Although the reduced food 
intake or poor absorption of nutrients play a key role in most 
cases of PEW, other factors in addition to starvation 
(especially hypermetabolism, inflammation, metabolic 
acidosis, comorbidities and dialysis) are required for the 
occurrence of PEW 13, 14. 
It was postulated that inflammation can cause PEW. 
Many factors, such as increased production and decreased 
elimination of proinflammatory cytokines, acidosis, 
oxidative stress, altered metabolism of adipose tissue, and 
other intracorporeal factors, contribute to persistent 
inflammation in CKD, especially in the HD patients. In 
addition to these, many extracorporeal factors mainly related 
to dialysis itself, such as chemical and microbiological 
contaminants in dialysis water, or bioincompatible in dialysis 
circuit, cannot be neglected 13, 20, 22. Kidney has a role of a 
modulator of endocrine function, whilst kidney disease 
Table 1 
Causes of PEW in CKD patients 13 
1. Decreased protein and energy intake 
a) Anorexia 
i. dysregulation in circulating appetite mediators 
ii. hypothalamic amino acid sensing 
iii. nitrogen-based uremic toxins 
b) Dietary restrictions 
c) Alterations in organs involved in nutrient intake 
d) Depression 
e) Inability to obtain or prepare food 
2. Hypermetabolism 
a) Increased energy expenditure 
i. inflammation 
ii. increased circulating proinflammatory cytokines 
iii. insulin resistance secondary to obesity 
iv. altered adiponectin and resistin metabolism 
b) Hormonal disorders 
i. insulin resistance of CKD 
ii. increased glucocorticoid activity 
3. Metabolic acidosis 
4. Decreased physical activity 
5. Decreased anabolism 
a) decreased nutrient intake 
b) resistance to GH/IGF-1 
c) testosterone deficiency 
d) low thyroid hormone levels 
6. Comorbidities and lifestyle  
a) comorbidities (diabetes mellitus, CHF, depression, coronary artery disease, peripheral vascular disease) 
7. Dialysis 
a) nutrient losses into dialysate 
b) dialysis-related inflammation 
c) dialysis-related hypermetabolism 
d) loss of residual renal function 
PEW – protein-energy wasting; CKD – chronic kidney disease; GH – growth hormone;  
IGF-1 – insulin-like growth factor 1; CHF – chronic heart failure. 
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causes abnormalities in the synthesis, excretion, and action 
of many hormones. Insulin resistance, growth hormone 
(GH), insulin-like growth factor (IGF)-1, and elevated 
glukucocorticoides levels are causative of an increase in 
protein and amino acid catabolism and suppression of protein 
synthesis. Thus, these are implicated in the loss of muscle 
mass in the CKD patients 2, 13, 20. Inflammation is associated 
with increased resting energy expenditure (REE), oxidative 
stress, protein catabolism, loss of muscle mass, high C-reactive 
protein and proinflammatory cytokine levels, hypoalbuminemia 
and the presence of comorbid conditions as well as with 
suppression of hormones such as anabolic hormones, IGF-1, and 
Table 2 
Readily utilizable criteria proposed by International Society of Renal Nutrition and Metabolism (ISRNM) expert panel 
for the clinical diagnosis of PEW in CKD 10 
Criteria 
Serum chemistry 
serum albumin < 3.8 g/dL (method: Bromcresol Green)a 
serum prealbumin (transthyretin) < 30mg/dL (for maintenance dialysis patients only; levels may vary according to GFR level for pa-
tients with CKD stages 2–5)a 
serum cholesterol < 100 mg/ dLa 
Body mass 
BMI < 23 kg/m2 b 
unintentional weight loss over time: 5% over 3 months or 10% over 6 months 
total body fat percentage < 10% 
Muscle mass 
muscle wasting: reduced muscle mass 5% over 3 months or 10% over 6 months 
reduced mid-arm muscle circumference areac (reduction > 10% in relation to 50th percentile of reference population) 
creatinine appearanced 
Dietary intakee 
unintentional low DPI < 0.80 g/kg/day- for at least 2 months for dialysis patients or < 0.6 g /kg/day for patients with CKD stages 2–5 
unintentional low DEI < 25 kcal/kg/day for at least 2 months  
At least three out of the four listed categories (and at least one test in each of the selected category) must be satisfied for the 
diagnosis of kidney disease-related PEW. 
Optimally, each criterion should be documented on at least three occasions, preferably 2–4 weeks apart. 
aNot valid if low concentrations are due to abnormally great urinary or gastrointestinal protein losses, liver disease, or choles-
terol-lowering medicines. 
bA lower BMI might be desirable for certain Asian populations; weight must be edema-free mass, for example, post-dialysis 
dry weight.  
cMeasurement must be performed by a trained anthropometrist. 
dCreatinine appearance is influenced by both muscle mass and meat intake. 
eCan be assessed by dietary diaries and interviews, or for protein intake by calculation of normalized protein equivalent 
of total nitrogen appearance (nPNA or nPCR) as determined by urea kinetic measurements. 
BMI – body mass index; CKD – chronic kidney disease; DEI – dietary energy intake; DPI – dietary protein intake; GFR 
– glomerular filtration rate; nPCR – normalized protein catabolic rate; nPNA – normalized protein nitrogen appearance; 
PEW – protein–energy wasting. 
 
Table 3 
Other potential tools (including those still in development) for assessment of PEW in individuals with CKD stages 3–5 10 
Appetite, food intake, and energy expenditure 
appetite assessment questionnaires 
population-based dietary assessments: food frequency questionnaires 
measuring energy expenditure by indirect or direct calorimetry 
Body mass and composition 
weight-based measures: weight-for-height 
total body nitrogen 
total body potassium 
energy-beam-based methods: DEXA, NIR, BIA, and vector bioimpedance analysis  
underwater weighing and air displacement weighing 
14 kDa fragment of actomyosin 
microarrays 
muscle fiber size 
relative proportions of muscle fiber types 
muscle alkaline soluble protein 
CT and/or MRI of muscle mass 
Laboratory markers 
serum biochemistry: transferrin, urea, triglyceride, bicarbonate 
hormones: leptin, ghrelin, growth hormones 
inflammatory markers: CRP, IL-6, TNF-α, IL-1, SAA 
peripheral blood cell count: lymphocyte count or percentage 
Nutritional scoring systems 
SGA and its modifications. 
PEW – protein-energy wasting; CKD – chronic kidney disease. 
BIA – bioelectrical impedance analysis; CRP – C-reactive protein; CT – computed tomography; DEXA – dualenergy X-ray 
absorptiometry; IL – interleukin (e.g., IL-1 and IL-6); MRI – magnetic resonance imaging; NIR – near infrared interact-
ance; SAA – serum amyloid A; SGA – subjective global assessment of nutritional status; TNF-α – tumor necrosis factor-α. 
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testosterone. Pro-inflammatory cytokines may directly decrease 
appetite and increase REE via influence on the central nervous 
system. They can also indirectly reduce the appetite in the CKD 
patients, through depression and consequently reduced dietary 
nutrients intake 13, 22, 23. 
Metabolic acidosis, often in the HD patients, is also a 
potential cause of PEW. Studies have shown that acidosis 
increases degradation of the whole-body protein, breakdown 
of the skeletal muscle protein and oxidation of branched 
chain amino acids decreases albumin synthesis and 
determines nutritional abnormalities. It also causes insulin 
resistance that leads to loss of muscle mass 13, 20. Some of 
comorbidities associated with CKD such as diabetes and 
metabolic syndrome, cardiovascular disease, 
hyperparathyroidism, anemia, gastrointestinal disorders, 
autoimmune and rheumatologic disorders, chronic lung 
diseases, liver disease, psychiatric and neurologic disorders 
and, malignant diseases, contribute to PEW 13. 
Although inadequate dialysis can lead to PEW itself, 
some factors associated with dialysis may contribute to PEW 
through nutrient losses into dialysate, infectious, 
inflammation, hypermetabolism and loss of residual renal 
function. Amino acid and protein losses during the dialysis 
session, together with low nutrients intake, promote low 
availability of nutrients for muscle synthesis. Dialysate loss of 
proteins, including amino acids, peptides and whole proteins, are 
estimated to be approximately 10–12 g per session. Dialyses 
procedure is a catabolic event, that accelerates the rate of whole-
body and muscle proteolysis and stimulates active muscles on 
the release of amino acids, raising net whole-body and muscle 
protein loss. These undesirable effects of net skeletal muscle 
protein breakdown persisted for at least 2 hours after the 
completion of the HD procedure. Simultaneous amino acid 
supplementation can prevent or reverse these adverse effects in 
the HD patients which can be an opportunity for the treatment of 
PEW 2, 13, 20, 24, 25. 
Diagnostic criteria for PEW 
Clinical guidelines recommend routine assessment of 
nutritional status in the CKD and HD patients. There is not a 
single specific measurement that provides complete 
assessment of the nutritional status of the HD patients, 
although many different parameters for assessing the PEW 
are used in clinical practice and research 5, 15, 26, 27. Therefore, 
the ISRNM established a set of criteria for identifying PEW 
in the CKD patients. According to the ISRNM expert panel 
diagnostic criteria, PEW has 4 categories in assessment: 
biochemical indicators, body mass, muscle mass and dietary 
intake. The ISRNM recommended that the diagnosis of PEW 
at least 3 out of 4 criteria categories, and that at least one test 
from each of the selected categories must be abnormal, on at 
least 3 examinations 2–4 weeks apart. Then, as a potential 
indicator of the PEW additional measures of nutrition and 
inflammation are recommended (Table 2) 10. 
Biochemical indicators 
Among biochemical indices, serum albumin concentration 
has been used in detection of malnutrition in the HD patients for 
a long time. Low serum albumin level is a relatively late 
manifestation of malnutrition, since albumin has a long half-life 
and hepatic synthetic reserve is very large 10, 15, 26. The 
association between serum albumin levels and mortality is 
highly gradual and linear. A decrease of 0.3 g/dL in serum 
albumin levels is associated with an increased risk of 
mortality by 20% in the HD patients 3. However, serum 
albumin is also influenced by several non-nutritional factors 
which are often present in the HD patients, including 
infection, inflammation, comorbidity and hydration status. 
Serum albumin should always be taken into account when 
assessing malnutrition in the HD patients. Thus, low albumin 
level in the HD patients may not always result from PEW, 
and albumin alone is not a clinically useful marker for PEW. 
The serum albumin concentration should be measured 
monthly 5, 10, 26, 28. Prealbumin, or transthyretin has a shorter 
half-life than albumin, a close relationship with nutritional 
status, and acts as a good predictor of clinical outcome in the 
HD patients 5, 10, 26, 28. The serum total cholesterol 
concentration is reduced in PEW. It is a less sensitive 
nutritional marker, cheap, and more accessible 5, 10, 26. 
Although, the expert panel did not recommend 
numerous laboratory markers as part of criteria for the 
diagnosis of PEW, such as serum transferrin, bicarbonate, 
urea, triglyceride, hormones (leptin, ghrelin, growth 
hormones) concertation, inflammatory markers (CRP, IL-6, 
TNF-α, IL-1, SAA) levels and lymphocyte count or 
percentage, they could be useful indicators of protein-energy 
nutritional status in maintenance dialysis patients and 
potential tools for assessing PEW (Table 3) 10. 
Body mass index (BMI) 
Even though BMI is one of the most used indicators of 
body mass, it has some limitations 29. In general population 
normal range of BMI is between 18.5 and 24.9 kg/m2, while 
according to the ISRNM criteria, BMI less than 23 kg/m2 is a 
marker of PEW in the HD patients 10, 26, 30. A higher BMI is 
associated with increased cardiovascular mortality in the 
general population. It is quite the opposite situation in the 
HD patients where higher BMI is associated with lower 
death risk (“obesity paradox”) 31. While obesity is a long-
term risk for cardiovascular diseases in general population, 
in  the HD patients, the risk mentioned above is not crucial. 
In the CKD patients risk of short-term consequences related 
to PEW is much greater than the risk of obesity, thus 
mortality depends on short-term risk meaning malnutrition. 
Therefore, in the CKD patients, especially in the HD 
patients, it is crucial to improve their nutritional status and 
prevent malnutrition and PEW 1. All anthropometric 
measurements should be performed after a routine HD 
session and must be performed by trained personnel 5, 10, 26. 
Since BMI is influenced by hydration status, it is 
recommended to use an edema-free mass to calculate BMI. 
Unintentional edema-free weight loss of 5% over 3 months 
or 10% during 6 months indicate risk of PEW 10. 
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Muscle mass 
Reduced muscle mass is one of the most important 
criteria for the presence of PEW 10. Mid-arm muscle 
circumference (MAMC) is useful in assessment of muscle 
mass. MAMC depends upon lean body mass and body water. 
It is thus expected that MAMC could increase when body 
water increases, although the lean body mass and somatic 
protein can be kept stable. It is necessary to bear this in mind 
when using MAMC in the HD patients as an index of 
somatic proteins status 5, 26. 
Dietary intake 
To evaluate the nutrition status, it is important to 
provide an adequate assessment of the food intake by some 
of the available methods like dietary diaries or interviews 5,
10, 26. In metabolic stable patients, it may be useful to 
indirectly assess dietary intake of protein by counting 
normalized protein equivalent of total nitrogen appearance 
(nPNA) 5, 10, 26. As food data collection, the following tools 
can be used: 24-hour recall, food diaries, and food frequency 
questionnaire (FFQ), but each of these tools has some 
limitations. 24-hour dietary recall covers a short period of 
time and it does not represent a typical food intake. Food 
diary covers a longer time period (3–7 days) and it is 
recommended to patients to include dialysis and non-dialysis 
days. It is a more useful tool, if the patient weighs the 
portions of food 32. FFQ can estimate the long term dietary 
intake. A diet that contains a daily energy intake of 35 
kcal/kg body weight (bw) (30–35 kcal/kg bw for those aged 
60 years and older) and 1.2 g protein/kg bw (at least 50% is 
of high biological value), is usually prescribed for the HD 
patients 1, 5. According to the ISRNM expert panel, 
unintentional low dietary protein intake less than 0.80 g/kg 
bw/day and unintentional low dietary energy intake less than 
25 kcal/kg bw/day for at least 2 months can be associated 
with PEW 10. 
According to the ISRNM, nutritional scoring systems 
were not included in diagnostic criteria of PEW (only in 
potential tools), but others advised subjective global 
assessment (SGA) and its modifications for dialysis 
malnutrition score (DMS), and malnutrition inflammation 
score (MIS) for the diagnosis of malnutrition in the HD 
patients 5, 8, 10, 26, 33. SGA is based on history and physical 
examination, and gives a global score of protein-energy 
nutritional status. SGA is a practical, inexpensive, easily 
doable clinical tool, with one potential problem – its 
subjective nature which may reduce its reproducibility. SGA 
should be used in combination with other measures in 
diagnosis of PEW 10, 33 Body composition, except by 
anthropometry, can be assessed by more sophisticated 
methods such as bioelectrical impedance analysis (BIA) or 
dual energy X-ray absorptiometry (DEXA). There is a good 
correlation between anthropometry and BIA and DEXA but 
they are expensive and not widely available 5, 10. 
Monitoring 
Nutritional status is considered an important prognostic 
factor for the risk of mortality, so early diagnosis and 
nutritional interventions could improve clinical outcome in 
the HD patients. Therefore, regular screening of the HD 
patients on PEW is extremely important. Nutritional status of 
the HD patients should be assessed at the start of HD and 
reassessed every 3–6 months. Malnourished and unstable 
patients may require monitoring at shorter intervals. 
Individual parameters such as serum albumin, BMI, nPNA, 
midweek predialysis creatinine should be evaluated monthly, 
but body weight should be measured on each dialysis 2, 5, 26. 
Conclusion 
The available evidence suggests that nutritional status 
in the HD patients is an extremely important predictive and 
causative factor for the good clinical outcome. Nutritional 
deficits and PEW are frequent problems in the dialysis 
population and implies an increased risk of negative health 
outcomes such as mortality risk and quality of life 
deterioration. There is no single specific measurement that 
provides complete assessment of the nutritional status in the 
HD patients, and the results should be analysed in the 
clinical context of each individual patients. As malnutrition 
is potentially reversible with appropriate nutritional support, 
early identification of patients at high nutritional risk may 
facilitate effective treatment and improve prognosis in the 
HD patients. 
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